Metastasis: Clinical Trials

3 trials for Metastasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Unknown 2, Completed 1

Follow Metastasis: new trials by email Literature Review of Metastasis trials Research Report on Metastasis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma
Selenium Yeast, Placebo - Selenium Deficiency, Thyroid Cancer TNM Staging
Phase 4UnknownQianfoshan Hospital50002022-05-302022-03-14
4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases
Pamidronate, Denosumab, Zoledronate - Breast Cancer, Prostate Cancer
Phase 4CompletedOttawa Hospital Research Institute2632016-08-012020-12-02
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
transarterial chemoembolization (TACE), Sorafenib - Hepatocellular Carcinoma, Metastasis
Phase 4UnknownKorea University1302012-03-012018-05-08

Narrower conditions

Neoplasm Metastasis (3)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Prostatic Neoplasms (1)  ·  Recurrence (1)  ·  Thyroid Neoplasms (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Neoplastic Processes (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Adenocarcinoma (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Disease Attributes (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)

Interventions

Denosumab (1)  ·  Pamidronate (1)  ·  Sorafenib (1)  ·  Zoledronic Acid (1)

Sponsors

Korea University (1)  ·  Ottawa Hospital Research Institute (1)  ·  Qianfoshan Hospital (1)

Countries

Canada (1)  ·  China (1)  ·  South Korea (1)

Top investigators

Hyung Joon Yim, M.D. (1)  ·  Lin Liao, Doctor (1)  ·  Mark Clemons, MD (1)

Results publications

PMID 11981766, PMID 12049862, PMID 12091661, PMID 12540794, PMID 18650514, PMID 19095497, PMID 21605146, PMID 34068083